Infection News

Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.

A third dose of COVID-19 vaccine can boost serological and T-cell response among most patients who are immunocompromised, according to data published in The Lancet Rheumatology.

The SLE Severe Infection Score-Revised, an updated score for predicting severe infections in systemic lupus erythematosus, is more accurate and feasible than the prior version, according to data published in Lupus Science & Medicine.

COVID-19 antibodies are significantly reduced by 6 months post-vaccination among patients with immune-mediated inflammatory diseases, according to data published in The Journal of Rheumatology.

Incidence of Henoch-Schönlein purpura waned and waxed significantly with the implementation and relaxation of non-pharmaceutical interventions against COVID-19, according to data published in JAMA Network Open.

An automated algorithm designed to identify rheumatology patients who need to “shield” against COVID-19 demonstrated results that matched the “gold standard” of manual review in the majority of cases, according to data.

Since the beginning of the COVID-19 pandemic, there has been a “significant decrease” in the risk for post-acute sequelae of COVID-19 among patients with rheumatic diseases, according to data published in The Journal of Rheumatology.

Approximately 25% of patients with COVID-19 who are immunocompromised remain positive for the disease 21 days or more from initial onset, according to data published in The Lancet Microbe.

Patients with a history of COVID-19 demonstrate a higher risk for new-onset autoimmune inflammatory rheumatic diseases, with greater infection severity linked to greater risk, according to data published in the Annals of Internal Medicine.

SCOTTSDALE, Ariz. — Physical medicine and rehabilitation play an important role in recovering from fatigue symptoms in immune-mediated diseases, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.